A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients (clinicaltrials.gov) - Dec 17, 2025 - P3 | N=105 | Recruiting | Sponsor: Children's Oncology Group | Active, not recruiting ➔ Recruiting
Enrollment open • Cytomegalovirus Infection • Hematological Malignancies • Infectious Disease • Oncology • Pediatrics • Solid Tumor • Transplantation
|